In one study, oral tofacitinib (Xeljanz
With a US presence spanning 40 years, Novo Nordisk US is headquartered in New Jersey and employs approximately 10,000 people throughout the country across more than 10 manufacturing, R&D, and corporate locations in seven states plus Washington, DC
Obesity Science & Innovation Sep 24, 2026 TO Sep 25, 2025 | Boston, MA The Obesity Science & Innovation event drives the future of obesity therapeutics by bringing together the most innovative companies with the right partners
Patients should only use any supplied product in accordance with the instructions provided
Reduce dose by 50% for 35 days, then re-escalate slowly
Yes, it helps shuttle fatty acids for energy but that doesnt create dramatic metabolic changes